Stay updated on RESILIENT Clinical Trial
Sign up to get notified when there's something new on the RESILIENT Clinical Trial page.

Latest updates to the RESILIENT Clinical Trial page
- CheckyesterdayChange DetectedThe page has undergone significant content changes, including the removal of detailed study information regarding the efficacy and safety of BYM338 in patients with sporadic inclusion body myositis, and the revision number has been updated from v2.14.4 to v2.15.0.SummaryDifference10%
- Check8 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.1%
- Check16 days agoChange DetectedThe web page has been updated to include new helpful links related to Novartis Pharmaceuticals and the clinical trial results for CBYM338B2203, reflecting the latest version revision from v2.14.2 to v2.14.3.SummaryDifference1%
- Check23 days agoNo Change Detected
- Check52 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference1%
- Check66 days agoChange DetectedThe web page now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.SummaryDifference1%
- Check73 days agoChange DetectedThe website has been updated from version 2.14.1 to 2.14.2.SummaryDifference0.1%
Stay in the know with updates to RESILIENT Clinical Trial
Enter your email address, and we'll notify you when there's something new on the RESILIENT Clinical Trial page.